Font Size: a A A
Keyword [candidiasis]
Result: 181 - 200 | Page: 10 of 10
181. Pharmacodynamic Effect And Mechanism Study Of Kangfuxin Liquid On Simple Vulvovaginal Candidiasis
182. Establishment Of A Mouse Model Of Recurrent Vulvovaginal Candidiasis And The Study Of The Changes Of Vaginal Local Immune Factors In The Different Stages
183. Retrospective Analysis Of Epidemiological And Clinical Features Of Esophageal Candidiasis
184. Relationship Between Vaginal Microecology And High-risk Human Papillomavirus Infection
185. Identification Of Vaginal Lactobacillus And Analysis Of Vaginal Microbiota In Reproductive-age Women
186. Effects Of Butyl Alcohol Extract Of Baitouweng Decoction And Three Main Components On Chemotaxis Of Neutrophils In Vulvovaginal Candidiasis Mice
187. Clinical Observation Of Xiajiaoqingtang In The Treatment Of Vulvovaginal Candidiasis (damp-heat Betting Syndrome)
188. Observation Of The Clinical Effect Of Antibacterial Photodynamic Therapy (APDT) On AIDS Combined With Oral Candidiasis Albicans
189. Clinical Study On The Effect Of Shenbai Xunyu Fang On VVC Vagina Microecological Flora
190. The Tutor's Experience And Literature Research On The Treatment Of Recurrent Vulvovaginal Candidiasis From The Spleen
191. Observation Of The Clinical Efficacy Of Baofukang Suppository Combined With Clotrimazole Vaginal Tablets In The Treatment Of Vulvovaginal Candida Disease
192. Th17-mediated responses in oral candidiasis: Redefining antifungal immunity
193. Farnesol is a virulence factor in a mouse model of disseminated candidiasis
194. Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals
195. Identification and characterization of potential virulence factors expressed by Candida albicans during oropharyngeal candidiasis in HIV-infected patients
196. Development & evaluation of a topical dosage form for the delivery of fluconazole for treating vulvovaginal candidiasis
197. Burden of candidiasis-related mortality in the United States and evaluation of comorbid illness risk factors: A multiple-cause-of-death study, 1990 - 2006
198. Interleukin-17-mediated adaptive immunity to Candida albicans in oropharyngeal candidiasis
199. Role of mucinolytic activity of Candida albicans in the pathogenesis of mucosal and invasive candidiasis
200. Binding Affinity and Antifungal Activity of Immune-Fusion Proteins against Candida albican
  <<First  <Prev  Next>  Last>>  Jump to